Pacira Pharmaceuticals, a pharmaceutical company developing a non-opioid postsurgical analgesic, filed on Tuesday with the SEC to raise up to $86 million in an initial public offering. The Parsippany, NJ-based company, which was founded in 2006 and booked $16 million in sales over the last 12 months, plans to list on the NASDAQ under the symbol PCRX. Barclays Capital and Piper Jaffray are the lead underwriters on the deal. No pricing terms were disclosed.
